Key result
A novel biodegradable inferior vena cava filter demonstrated progressive degradation, good biocompatibility, and a mean in vitro thrombus trapping efficiency of 90%.
Why the study?
Complications following conventional inferior vena cava filter implantation hinder clinical application, prompting the need for a biodegradable alternative to prevent pulmonary embolism.
Does a novel biodegradable inferior vena cava filter demonstrate adequate mechanical properties, degradation, biocompatibility, and thrombus trapping efficiency in vitro?
Comparison
Novel biodegradable inferior vena cava filter vs traditional inferior vena cava filter
Design
In vitro preclinical design and evaluation study
Follow-up
Six months
Authors
Loading...
Novel biodegradable IVC filter shows mechanical feasibility; leaves open clinical safety and efficacy in PE prevention.
Does a novel biodegradable inferior vena cava filter demonstrate adequate mechanical properties, degradation, biocompatibility, and thrombus trapping efficiency in vitro?
A novel biodegradable inferior vena cava filter demonstrates favorable mechanical properties, progressive degradation, biocompatibility, and high thrombus trapping efficiency in vitro, suggesting potential for temporary VTE prevention.
Yang et al. (2019) studied Venous thromboembolism. Novel biodegradable inferior vena cava filter vs. Traditional inferior vena cava filter was evaluated on Thrombus trapping efficiency (for 5 mm × 10 mm sized thrombus). A novel biodegradable inferior vena cava filter demonstrated progressive degradation, good biocompatibility, and a mean in vitro thrombus trapping efficiency of 90%.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: